YHLO innovative iFlash series showcased at the 2022 AACC Expo
From July 26-28, YHLO was showcased at the American Association of Clinical Chemistry 2022 Clinical Lab Expo. The YHLO exhibit booth featured the Chemiluminescence Immunoassay solutions that can provide labs with better efficiency and reliability. And the highly-automated Mono-test Analyzer iStar 500, the Immunofluorescence Reader Unicell and the Vision ESR Analyzer are also showcased to attendees.
The 2022 AACC Clinical Lab Expo also featured 781 exhibitors and covered 246,700 net square feet. YHLO met a lot of old friends and new friends here in the YHLO booth (#1044) and showcased the exciting total solutions for immunoassays.
Attachments:
MORE NEWS
n November 18, 2025, YHLO’s 2025 Global Core Distributors Conference was successfully held in Düsseldorf, Germany. Under the theme “Academia-Driven, Shared Value,” the meeting brought together representatives from more than 30 core distributors worldwide. YHLO’s founder, Mr. Deming Hu, and Chairman, Mr. Kunhui Hu, led the company’s executive team to attend and discuss strategic development with partners.
2025-11-20
YHLO Secures Approval for the World’s First sCD146 CLIA Assay
YHLO has obtained approval from the Guangdong Medical Products Administration for its soluble CD146 (sCD146) CLIA assay, marking a major milestone in central nervous system (CNS) disease diagnostics. YHLO is now the first company worldwide to offer an sCD146 test for cerebrospinal fluid, bringing its total CLIA assay portfolio in China to 173.
2025-11-18
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
